These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26588986)

  • 1. Clinical value of cardiovascular magnetic resonance in patients with MR-conditional pacemakers.
    Raphael CE; Vassiliou V; Alpendurada F; Prasad SK; Pennell DJ; Mohiaddin RH
    Eur Heart J Cardiovasc Imaging; 2016 Oct; 17(10):1178-85. PubMed ID: 26588986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular magnetic resonance in patients with magnetic resonance conditional pacemaker systems at 1.5 T: influence of pacemaker related artifacts on image quality including first pass perfusion, aortic and mitral valve assessment, flow measurement, short tau inversion recovery and T1-weighted imaging.
    Klein-Wiele O; Garmer M; Busch M; Mateiescu S; Urbien R; Barbone G; Kara K; Schulte-Hermes M; Metz F; Hailer B; Grönemeyer D
    Int J Cardiovasc Imaging; 2017 Mar; 33(3):383-394. PubMed ID: 27815793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T.
    Holtstiege V; Meier C; Bietenbeck M; Chatzantonis G; Florian A; Köbe J; Reinke F; Eckardt L; Yilmaz A
    J Cardiovasc Magn Reson; 2020 May; 22(1):35. PubMed ID: 32418537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: a device-dependent imaging strategy for improved image quality.
    Hilbert S; Jahnke C; Loebe S; Oebel S; Weber A; Spampinato R; Richter S; Doering M; Bollmann A; Sommer P; Hindricks G; Paetsch I
    Eur Heart J Cardiovasc Imaging; 2018 Sep; 19(9):1051-1061. PubMed ID: 29048460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deactivation vs. asynchronous pacing - prospective evaluation of a protocol for rhythm management in patients with magnetic resonance conditional pacemakers undergoing adenosine stress cardiovascular magnetic resonance imaging.
    Klein-Wiele O; Garmer M; Barbone G; Urbien R; Busch M; Kara K; Schäfer H; Schulte-Hermes M; Hailer B; Grönemeyer D
    BMC Cardiovasc Disord; 2017 Jun; 17(1):142. PubMed ID: 28577544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and safety of adenosine cardiovascular magnetic resonance in patients with MR conditional pacemaker systems at 1.5 Tesla.
    Klein-Wiele O; Garmer M; Urbien R; Busch M; Kara K; Mateiescu S; Grönemeyer D; Schulte-Hermes M; Garbrecht M; Hailer B
    J Cardiovasc Magn Reson; 2015 Dec; 17():112. PubMed ID: 26695427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing cardiac implantable electronic device-induced artefacts in cardiac magnetic resonance imaging.
    Vuorinen AM; Lehmonen L; Karvonen J; Holmström M; Kivistö S; Kaasalainen T
    Eur Radiol; 2023 Feb; 33(2):1229-1242. PubMed ID: 36029346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of adenosine stress cardiovascular magnetic resonance perfusion imaging in patients with MR-conditional transvenous permanent pacemakers and defibrillators.
    Pavon AG; Porretta AP; Arangalage D; Domenichini G; Rutz T; Hugelshofer S; Pruvot E; Monney P; Pascale P; Schwitter J
    J Cardiovasc Magn Reson; 2022 Jan; 24(1):9. PubMed ID: 35022037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices.
    Do DH; Eyvazian V; Bayoneta AJ; Hu P; Finn JP; Bradfield JS; Shivkumar K; Boyle NG
    Heart Rhythm; 2018 Feb; 15(2):218-225. PubMed ID: 29017930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, feasibility, and prognostic value of stress perfusion CMR in patients with MR-conditional pacemaker.
    Pezel T; Lacotte J; Horvilleur J; Toupin S; Hovasse T; Unterseeh T; Sanguineti F; Said MA; Salerno F; Fiorina L; Manenti V; Zouaghi A; Faradji A; Nicol M; Ah-Sing T; Dillinger JG; Henry P; Garot P; Bousson V; Garot J
    Eur Heart J Cardiovasc Imaging; 2023 Jan; 24(2):202-211. PubMed ID: 36214336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac MRI in patients with cardiac pacemakers: practical methods for reducing susceptibility artifacts and optimizing image quality.
    Kaasalainen T; Kivistö S; Holmström M; Peltonen J; Pakarinen S; Hänninen H; Sipilä O
    Acta Radiol; 2016 Feb; 57(2):178-87. PubMed ID: 25766728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artefacts in 1.5 Tesla and 3 Tesla cardiovascular magnetic resonance imaging in patients with leadless cardiac pacemakers.
    Kiblboeck D; Reiter C; Kammler J; Schmit P; Blessberger H; Kellermair J; Fellner F; Steinwender C
    J Cardiovasc Magn Reson; 2018 Jul; 20(1):47. PubMed ID: 29973228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An echo-planar imaging sequence is superior to a steady-state free precession sequence for visual as well as quantitative assessment of cardiac magnetic resonance stress perfusion.
    Ahlander BM; Maret E; Brudin L; Starck SA; Engvall J
    Clin Physiol Funct Imaging; 2017 Jan; 37(1):52-61. PubMed ID: 26147785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators.
    Sasaki T; Hansford R; Zviman MM; Kolandaivelu A; Bluemke DA; Berger RD; Calkins H; Halperin HR; Nazarian S
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):662-70. PubMed ID: 21946701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of cardiovascular magnetic resonance with optimized myocardial scar detection in patients with cardiac implantable devices.
    Bhuva AN; Kellman P; Graham A; Ramlall M; Boubertakh R; Feuchter P; Hawkins A; Lowe M; Lambiase PD; Sekhri N; Schilling RJ; Moon JC; Manisty CH
    Int J Cardiol; 2019 Mar; 279():72-78. PubMed ID: 30642645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: best practice and real-world experience.
    Seewöster T; Löbe S; Hilbert S; Bollmann A; Sommer P; Lindemann F; Bacevičius J; Schöne K; Richter S; Döring M; Paetsch I; Hindricks G; Jahnke C
    Europace; 2019 Aug; 21(8):1220-1228. PubMed ID: 31131393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial inflammation on cardiovascular magnetic resonance predicts left ventricular function recovery in children with recent dilated cardiomyopathy.
    Raimondi F; Iserin F; Raisky O; Laux D; Bajolle F; Boudjemline Y; Boddaert N; Bonnet D
    Eur Heart J Cardiovasc Imaging; 2015 Jul; 16(7):756-62. PubMed ID: 25711351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of cardiac magnetic resonance imaging for cardiac sarcoidosis in complete heart block patients implanted with magnetic resonance-conditional pacemaker.
    Orii M; Tanimoto T; Ota S; Takagi H; Tanaka R; Fujiwara J; Akasaka T; Yoshioka K
    J Cardiol; 2020 Aug; 76(2):191-197. PubMed ID: 32184028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and image quality of cardiovascular magnetic resonance imaging in patients with retained epicardial pacing wires after heart transplantation.
    Gatterer C; Stelzmüller ME; Kammerlander A; Zuckermann A; Krššák M; Loewe C; Beitzke D
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):24. PubMed ID: 33715632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular magnetic resonance at 0.5T in five patients with permanent pacemakers.
    Heatlie G; Pennell DJ
    J Cardiovasc Magn Reson; 2007; 9(1):15-9. PubMed ID: 17178676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.